When sales top 100 mil p/a in a couple of years for BSM alone and when you look at the huge mark up on that product and when Breastsling and hernia products come closer to fruition and/or diabetes / bone regeneration products ...........
330 mil might look quite cheap then
Not saying that this company will become another Cochlear but not saying it can't or won't either.
Ann: Change of Director's Interest Notice, page-11
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.28 |
Change
0.060(2.70%) |
Mkt cap ! $921.4M | |||
| Open | High | Low | Value | Volume |
| $2.24 | $2.29 | $2.21 | $619.2K | 273.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 45 | 18472 | $2.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.28 | 4955 | 19 |
View Market Depth
| Last trade - 13.00pm 05/12/2024 (20 minute delay) ? |
| PNV (ASX) Chart |